<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bamias, A.</style></author><author><style face="normal" font="default" size="100%">Lainakis, G.</style></author><author><style face="normal" font="default" size="100%">Manios, E.</style></author><author><style face="normal" font="default" size="100%">Koroboki, E.</style></author><author><style face="normal" font="default" size="100%">Karadimou, A.</style></author><author><style face="normal" font="default" size="100%">Zakopoulos, N.</style></author><author><style face="normal" font="default" size="100%">Dimopoulos, M.A.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Could rigorous diagnosis and management of hypertension reduce cardiac events in patients with renal cell carcinoma treated with tyrosine kinase inhibitors?</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Clinical Oncology</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2009</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-66349094554&amp;doi=10.1200%2fJCO.2008.21.6028&amp;partnerID=40&amp;md5=8d7f92d9d91dab6845220f76fc3fbe94</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">27</style></volume><pages><style face="normal" font="default" size="100%">2567 - 2569</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><issue><style face="normal" font="default" size="100%">15</style></issue><notes><style face="normal" font="default" size="100%">Cited By :10Export Date: 21 February 2017</style></notes></record></records></xml>